CASSS On Demand

Access approved content from past meetings in the CASSS On Demand platform. CASSS members have access to all available presentation recordings. Visit ondemand.casss.org, login to your account, and select from the list of meetings to begin.
Explore CASSS
On Demand

Papers and Presentations

How to Search for Resources

You can search for a variety of content on the CASSS website. CASSS makes available any content with author approval. Narrow your search by using the various filters shown below, such as Resource Type, Event Type, and Year. Refine your search as needed.

Refine Results

Filter By Event Types

Filter By Tags

CMC Summary Paper

Displaying results 1 - 20 of 55

Best Practices for In-Use Stability and Compatibility Studies

Summary Papers: CMC Strategy Forum North America 2024
Comparability for Cell and Gene Therapy Products

Summary Paper: CGTP Summit 2023
CMC Strategies for Expedited Program Development — Regulatory Perspectives

CMC Summary Paper: CMC Strategy Forum North America Fall 2020
Creating CMC Strategies for Pandemics and Beyond

CMC Summary Paper: WCBP 2021 Special Edition
COVID-19 Vaccine Urgency Throws Spotlight on Next-Generation Sequencing for Adventitious Virus Control Japan

CMC Summary Paper: CMC Strategy Forum Japan 2020
Summary of 2016 CASSS CMC Strategy Forum Japan

CMC Summary Paper: CMC Strategy Forum Japan 2016
Summary of 2015 CMC Strategy Forum Japan

CMC Summary Paper: CMC Strategy Forum Japan 2015
Asian Agencies Report on Progress in Addressing Emerging Regulatory Challenges at CASSS Biotech CMC Strategy Forum in Japan

CMC Summary Paper: CMC Strategy Forum Japan 2014
Post-Approval Change Regulatory Burden Draws Heat at Japan Biotech CMC Strategy Forum

CMC Summary Paper: CMC Strategy Forum Japan 2013
Better Glycosylation Understanding Would Further International Biotech Regulatory Convergence Efforts, CMC Strategy Forum Participants Agree

CMC Summary Paper: CMC Strategy Forum Japan 2012
COVID-19 Vaccine Urgency Throws Spotlight on Next-Generation Sequencing for Adventitious Virus Control Europe

CMC Summary Paper: CMC Strategy Forum Europe 2020
EMA’s Draft Guideline on Drug-Device Combinations Sheds Needed Light on Expectations for Device Assessment

CMC Summary Paper: CMC Strategy Forum Europe 2019
CMC Priorities of EFPIA’s European Biopharmaceutical Enterprises Include ADCs, Drug/Device Combos and Statistics

CMC Summary Paper: CMC Strategy Forum Europe 2018
Accelerated Development and Review Initiatives in Focus at 2016 CASSS CMC Strategy Forum Europe

CMC Summary Paper: CMC Strategy Forum Europe 2016
Amgen “Analytics of the Future” Initiative Develops MS-based “Multi-Attribute Methodology” to Streamline Biotech Development and QC Testing

CMC Summary Paper: CMC Strategy Forum Europe 2014
EMA's Key Biotech Quality Initiatives in Focus at CASSS' 2012 CMC Strategy Forum Europe

CMC Summary Paper: CMC Strategy Forum Europe 2012
Improving Biopharmaceutical Product Quality: Moving Implementation Forward

CMC Summary Paper: CMC Strategy Forum Europe 2011
Challenges Facing Biopharmaceutical Development in the Next Decade

CMC Summary Paper: CMC Strategy Forum Europe 2010
Increased EMA/Industry Dialogue Needed to Address Upcoming Biopharm Regulatory Challenges, Retiring Quality Director Purves Says

CMC Summary Paper: CMC Strategy Forum Europe 2010 - 2
Life Cycle Approach for Specifications

CMC Summary Paper: CMC Strategy Forum Europe 2007

Displaying results 1 - 20 of 55